Comparing the demographics and laboratory biomarkers of the COVID-19 Omicron wave and the Alpha wave in a predominantly Afro-Caribbean patient population in New York City

Table 1 Characteristics of Alpha and Omicron Waves

Characteristic	All Patients by Wave (n = 298)			All Non-Survivors by Wave (n = 197)			Omicron Wave by Survival Status (n = 27)
	Alpha (n=271)	Omicron (n = 27)	p-value	Alpha (n=182)	Omicron (n = 15)	p-value	Survivor (n= 12)	Non-Survivor (n = 15)	p-value
	n (%)	n (%)		n (%)	n (%)		n (%)	n (%)
	271 (90.1%)	27 (9.06%)		182 (92.4%)	15 (7.61%)		12 (44.4%)	15 (55.6%)	0.56
Age (mean, sd.)	66.6 \(\pm\) 12.8	65.3 \(\pm\) 11.4	0.60	69 \(\pm\) 11.4	68.7 \(\pm\) 10.4	0.91	61.2 \(\pm\)11.7	68.7 \(\pm 10.4\)	0.09
Sex
Male	157 (57.9)	11 (40.7)	0.08	112 (61.5)	5 (33.3)	0.03	6 (50.0)	5 (33.3)	0.38
Female	114 (42.1)	16 (59.3)		70 (38.5)	10 (66.7)		6 (50.0)	10 (66.7)
Race
Black	239 (88.2)	23 (85.2)	0.54	165 (90.7)	15 (100)	0.67	8 (66.7)	15 (100.00)	0.12
White	11 (4.06)	1 (3.70)		7 (3.85)	0 (0)		1 (8.33)	0 (0.00)
Hispanic	6 (2.21)	0 (0)		2 (1.10)	0 (0)		0 (0.0)	0 (0.0)
Asian	2 (0.74)	1 (3.70)		0 (0)	0 (0)		1 (8.33)	0 (0.0)
Unknown	13 (4.80)	2 (7.41)		8 (4.40)	0 (0)		2 (16.7)	0 (0.0)
Comorbidities
Asthma	25 (9.23)	5 (18.5)	0.13	17 (9.34)	3 (20.0)	0.19	2 (16.7)	3 (20.0)	0.82
COPD	22 (8.12)	2 (7.41)	0.90	16 (8.79)	1 (6.67)	0.78	1 (8.33)	1 (6.67)	0.87
Diabetes	152 (56.1)	16 (59.3)	0.75	104 (57.1)	9 (60.0)	0.83	7 (58.3)	9 (60.0)	0.93
Hypertension	211 (77.9)	22 (81.5)	0.66	148 (81.3)	12 (80.0)	0.90	10 (83.3)	12 (80.0)	0.82
HIV	8 (2.95)	1 (3.70)	0.83	7 (3.85)	0 (0)	0.44	1 (8.33)	0 (0.00)	0.25
CKD	41 (15.1)	7 (25.9)	0.15	29 (15.9)	5 (33.3)	0.09	2 (16.7)	5 (33.3)	0.33
Covid-19 Vaccination Status
Yes							4 (33.3)	8 (53.3)	0.15
No							8 (66.7)	5 (33.3)
Unknown							0 (0)	2 (13.3)

ISSN: 2200-6133